Skip to content
Research Article Open access CC BY 4.0

Hyphema Post Intravitreal Injection of Bevacizumab

Lucrèce Joanelle Vydalie Eriga, Arnaud Hugues Yempabou Yonli, Ricardo Mendes, Yassine Mouzari, Abdelbarre Oubaaz

Asian Journal of Research and Reports in Ophthalmology · pp. 1–4 · Published 2 Jan 2024

Abstract

Objective: To describe a case of total hyphema after intravitreal injection of Bevacizumab. Results: This is a 54 years old patient diagnosed with exudative age-related macular degeneration who was admitted for injection of Bevacizumab in the right eye. The visual acuity was 02/10 in both eyes, and the injection was performed after eliminating the contraindications on biomicroscope examination. The immediate evolution after injection was marked by a total hyphema. The management was based on antibiotic and anti-inflammatory eye drops, rehydration and monitoring. The hyphema disappeared after ten days with visual acuity remained at 02/10.

Hyphema bevacizumab exudative macular

Cited by 0

No indexed citations yet.

Article metrics

Real usage data collected on this platform.

0

Page views

0

PDF downloads

0

Outbound clicks

0

Citations

Views by country

Approximate, from request IP at view time — not citizenship or institution. Countries with fewer than 5 views are grouped as "Other".

No views recorded yet.

Traffic sources

Referring site, by host.

No traffic recorded yet.

Views and downloads exclude known bots/crawlers. Citations combines this platform's own DOI-resolved index with each external source's own reported total — see Cited by above for individually listed citing works. Last refreshed 0 seconds ago.